Endothelial nitric oxide synthase-independent release of nitric oxide in the aorta of the spontaneously hypertensive rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 344, Issue 1, 2013, Pages 15-22

  Zhao, Yingzi ^a   Vanhoutte, Paul M ^a,b   Leung, Susan W S ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Chonbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; APOCYNIN; CYTOCHROME P450 REDUCTASE; DIPHENYLIODONIUM SALT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRITE; OXYHEMOGLOBIN; PHENYLEPHRINE;

ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL TONE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTHELIUM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR RING; VASOCONSTRICTION; WISTAR KYOTO RAT;

ANIMALS; AORTA, THORACIC; CLOTRIMAZOLE; CYCLOOXYGENASE INHIBITORS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HUMANS; INDOMETHACIN; MALE; NADPH-FERRIHEMOPROTEIN REDUCTASE; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; ONIUM COMPOUNDS; PHENYLEPHRINE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SIGNAL TRANSDUCTION; VASOCONSTRICTOR AGENTS;

EID: 84871699693     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.198721     Document Type: Article

References (60)

1. Alaghband-Zadeh J, Das I, Hanson MR, MacGregor CA, de Wardener HE, and Laycock JF (1996) Hypothalamic and plasma total nitrate/nitrite concentrations in spontaneously hypertensive rats. Exp Physiol 81:881-883. (Pubitemid 26332087)
2. Alderton WK, Cooper CE, and Knowles RG (2001) Nitric oxide synthases: structure, function and inhibition. Biochem J 357:593-615. (Pubitemid 32735142)
3. Beretta M, Wölkart G, Schernthaner M, Griesberger M, Neubauer R, Schmidt K, Sacherer M, Heinzel FR, Kohlwein SD, and Mayer B (2012) Vascular bioactivation of nitroglycerin is catalyzed by cytosolic aldehyde dehydrogenase-2. Circ Res 110: 385-393.
4. Boulanger CM, Heymes C, Benessiano J, Geske RS, Lévy BI, and Vanhoutte PM (1998) Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension. Circ Res 83:1271-1278. (Pubitemid 29006042)
5. Brandes RP (2010) Vascular functions of NADPH oxidases. Hypertension 56:17-21.
6. Chen K, Pittman RN, and Popel AS (2008) Nitric oxide in the vasculature: where does it come from and where does it go? A quantitative perspective. Antioxid Redox Signal 10:1185-1198. (Pubitemid 351620307)
7. Chen Z, Zhang J, and Stamler JS (2002) Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci USA 99:8306-8311. (Pubitemid 34651048)
8. Chou TC, Yen MH, Li CY, and Ding YA (1998) Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 31:643-648.
9. Day BJ and Kariya C (2005) A novel class of cytochrome P450 reductase redox cyclers: cationic manganoporphyrins. Toxicol Sci 85:713-719. (Pubitemid 40614301)
10. Feelisch M and Noack EA (1987) Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol 139:19-30. (Pubitemid 17093700)
11. Félétou M, Verbeuren TJ, and Vanhoutte PM (2009) Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors. Br J Pharmacol 156: 563-574.
12. Furchgott RF (1993) Introduction to EDRF research. J Cardiovasc Pharmacol 22 (Suppl 7):S1-S2.
13. Furchgott RF and Vanhoutte PM (1989) Endothelium-derived relaxing and contracting factors. FASEB J 3 :2007-2018. (Pubitemid 19187609)
14. Furchgott RF and Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376. (Pubitemid 11169009)
15. Ge T, Hughes H, Junquero DC, Wu KK, Vanhoutte PM, and Boulanger CM (1995) Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H synthase-1 and hypersensitivity to prostaglandin H2 in the SHR aorta. Circ Res 76:1003-1010.
16. Graham DA and Rush JW (2004) Exercise training improves aortic endotheliumdependent vasorelaxation and determinants of nitric oxide bioavailability in spontaneously hypertensive rats. J Appl Physiol 96:2088-2096. (Pubitemid 38661485)
17. Griendling KK, Minieri CA, Ollerenshaw JD, and Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141-1148. (Pubitemid 24176909)
18. Gruetter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ, and Ignarro L (1979) Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J Cyclic Nucleotide Res 5:211-224. (Pubitemid 9246716)
19. Heumüller S, Wind S, Barbosa-Sicard E, Schmidt HHHW, Busse R, Schröder K, and Brandes RP (2008) Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51:211-217. (Pubitemid 351159930)
20. Higashi Y, Noma K, Yoshizumi M, and Kihara Y (2009) Endothelial function and oxidative stress in cardiovascular diseases. Circ J 73:411-418.
21. Keung WM, Klyosov AA, and Vallee BL (1997) Daidzin inhibits mitochondrial aldehyde dehydrogenase and suppresses ethanol intake of Syrian golden hamsters. Proc Natl Acad Sci USA 94:1675-1679. (Pubitemid 27113894)
22. Khadour FH, Kao RH, Park S, Armstrong PW, Holycross BJ, and Schulz R (1997) Age-dependent augmentation of cardiac endothelial NOS in a genetic rat model of heart failure. Am J Physiol 273:H1223-H1230.
23. Kozlov AV, Staniek K, and Nohl H (1999) Nitrite reductase activity is a novel function of mammalian mitochondria. FEBS Lett 454:127-130. (Pubitemid 29296938)
24. Lancaster JR, Jr (1997) A tutorial on the diffusibility and reactivity of free nitric oxide. Nitric Oxide 1:18-30.
25. Li H, Liu X, Cui H, Chen YR, Cardounel AJ, and Zweier JL (2006) Characterization of the mechanism of cytochrome P450 reductase-cytochrome P450-mediated nitric oxide and nitrosothiol generation from organic nitrates. J Biol Chem 281: 12546-12554. (Pubitemid 43855342)
26. Lundberg JO (2009) Cardiovascular prevention by dietary nitrate and nitrite. Am J Physiol Heart Circ Physiol 296:H1221-H1223.
27. Lundberg JO, Carlström M, Larsen FJ, and Weitzberg E (2011) Roles of dietary inorganic nitrate in cardiovascular health and disease. Cardiovasc Res 89: 525 -532.
28. Lundberg JO, Weitzberg E, and Gladwin MT (2008) The nitrate-nitrite- nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 7:156-167. (Pubitemid 351194063)
29. Lüscher TF, Diederich D, Weber E, Vanhoutte PM, and Bühler FR (1988) Endothelium-dependent responses in carotid and renal arteries of normotensive and hypertensive rats. Hypertension 11:573-578.
30. Machha A and Schechter AN (2011) Dietary nitrite and nitrate: a review of potential mechanisms of cardiovascular benefits. Eur J Nutr 50 :293-303.
31. Majander A, Finel M, and Wikström M (1994) Diphenyleneiodonium inhibits reduction of iron-sulfur clusters in the mitochondrial NADH-ubiquinone oxidoreductase (Complex I). J Biol Chem 269:21037-21042. (Pubitemid 24266472)
32. Martin W, Villani GM, Jothianandan D, and Furchgott RF (1985) Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 232:708-716. (Pubitemid 15135858)
33. McGuire JJ, Anderson DJ, McDonald BJ, Narayanasami R, and Bennett BM (1998) Inhibition of NADPH-cytochrome P450 reductase and glyceryl trinitrate biotransformation by diphenyleneiodonium sulfate. Biochem Pharmacol 56:881-893. (Pubitemid 28458982)
34. Moncada S, Gryglewski R, Bunting S, and Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663-665.
35. Moncada S, Korbut R, Bunting S, and Vane JR (1978) Prostacyclin is a circulating hormone. Nature 273:767-768. (Pubitemid 8357094)
36. Nava E, Noll G, and Lüscher TF (1995) Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation 91:2310-2313.
37. Nohl H, Staniek K, Sobhian B, Bahrami S, Redl H, and Kozlov AV (2000) Mitochondria recycle nitrite back to the bioregulator nitric monoxide. Acta Biochim Pol 47 :913-921.
38. O'Donnell BV, Tew DG, Jones OT, and England PJ (1993) Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem J 290:41-49. (Pubitemid 23081198)
39. Palmer RM, Ashton DS, and Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664-666.
40. Palmer RM, Ferrige AG, and Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526. (Pubitemid 17085822)
41. Pattillo CB, Bir S, Rajaram V, and Kevil CG (2011) Inorganic nitrite and chronic tissue ischaemia: a novel therapeutic modality for peripheral vascular diseases. Cardiovasc Res 89:533-541.
42. Portal P, Villamil SF, Alonso GD, De Vas MG, Flawiá MM, Torres HN, and Paveto C (2008) Multiple NADPH-cytochrome P450 reductases from Trypanosoma cruzi suggested role on drug resistance. Mol Biochem Parasitol 160:42-51. (Pubitemid 351699263)
43. Puig JG, Mateos FA, and Diaz VD (1989) Inhibition of xanthine oxidase by allopurinol: a therapeutic option for ischaemia induced pathological processes? Ann Rheum Dis 48:883-888. (Pubitemid 19280908)
44. Rand MJ and Li CG (1995) Discrimination by the NO-trapping agent, carboxy-PTIO, between NO and the nitrergic transmitter but not between NO and EDRF. Br J Pharmacol 116:1906-1910.
45. Ratz JD, McGuire JJ, Anderson DJ, and Bennett BM (2000) Effects of the flavoprotein inhibitor, diphenyleneiodonium sulfate, on ex vivo organic nitrate tolerance in the rat. J Pharmacol Exp Ther 293:569-577. (Pubitemid 30244109)
46. Ratz JD, McGuire JJ, and Bennett BM (1999) Enantioselective inhibition of the biotransformation and pharmacological actions of isoidide dinitrate by diphenyleneiodonium sulphate. Br J Pharmacol 126:61-68. (Pubitemid 29041744)
47. Rubanyi GM and Vanhoutte PM (1986) Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 250:H822-H827.
48. Stuehr DJ, Fasehun OA, Kwon NS, Gross SS, Gonzalez JA, Levi R, and Nathan CF (1991) Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J 5:98-103. (Pubitemid 21892842)
49. Tang EH, Jensen BL, Skøtt O, Leung GP, Félétou M, Man RY, and Vanhoutte PM (2008) The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats. Cardiovasc Res 78:130-138. (Pubitemid 351430954)
50. Tang EH, Leung FP, Huang Y, Félétou M, So KF, Man RY, and Vanhoutte PM (2007) Calcium and reactive oxygen species increase in endothelial cells in response to releasers of endothelium-derived contracting factor. Br J Pharmacol 151:15-23. (Pubitemid 46676000)
51. Tang EH and Vanhoutte PM (2008) Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension. Physiol Genomics 32:409-418. (Pubitemid 351328564)
52. Topal G, Koç E, and Karaca C, et al. (2012) Effects of Crataegus microphylla on vascular dysfunction in streptozotocin-induced diabetic rats. Phytother Res [published ahead of print]
53. van Faassen EE, Bahrami S, and Feelisch M, et al. (2009) Nitrite as regulator of hypoxic signaling in mammalian physiology. Med Res Rev 29:683-741.
54. Vanhoutte PM, Félétou M, and Taddei S (2005) Endothelium-dependent contractions in hypertension. Br J Pharmacol 144:449-458. (Pubitemid 40349452)
55. Vanhoutte PM, Shimokawa H, Tang EH, and Félétou M (2009) Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 196:193-222.
56. Vaziri ND, Ni Z, and Oveisi F (1998) Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 31:1248-1254. (Pubitemid 28248823)
57. Wolin MS (2000) Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol 20:1430-1442.
58. Wu CC and Yen MH (1999) Higher level of plasma nitric oxide in spontaneously hypertensive rats. Am J Hypertens 12:476-482.
59. Zalba G, Beaumont FJ, San José G, Fortuño A, Fortuño MA, and Díez J (2001) Is the balance between nitric oxide and superoxide altered in spontaneously hypertensive rats with endothelial dysfunction? Nephrol Dial Transplant 16 (1):2-5. (Pubitemid 32492496)
60. Zhukov A and Ingelman-Sundberg M (1999) Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is abolished by inactivation of its electron donor NADPH-cytochrome P450 reductase. Biochem J 340:453-458. (Pubitemid 29286566)